Kingswood Wealth Advisors’s aTyr Pharma ATYR Stock Holding History

Kingswood Wealth Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31K	Hold	52,000	–	–	﹤0.01%	991
2026 Q1	$40.6K	Hold	52,000	–	–	﹤0.01%	918
2025 Q4	$40.7K	Buy	+52,000	New	+$42.7K	﹤0.01%	862
2025 Q3	–	Sell	-36,000	Closed	-$183K	–	858
2025 Q2	$183K	Sell	36,000 -1,000	-3%	-$3.93K	0.01%	713
2025 Q1	$110K	Sell	37,000 -10,000	-21%	-$36.5K	0.01%	704
2024 Q4	$170K	Buy	+47,000	New	+$142K	0.01%	748
2024 Q2	–	Sell	-60,000	Closed	-$117K	–	718
2024 Q1	$117K	Buy	+60,000	New	+$105K	0.01%	596

Other funds holding ATYR

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HWM

Hohimer Wealth Management Seattle, Washington $1B AUM 33.02% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

AWF

Alpha Wealth Funds Park City, Utah $183M AUM 8.96% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Kingswood Wealth Advisors's ATYR Position: Q2 2026 in Review

Kingswood Wealth Advisors held its aTyr Pharma (ATYR) position steady in Q2 2026 at 52,000 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #991.

Kingswood Wealth Advisors first reported a position in ATYR in Q1 2024 and has held it in 7 quarters since. The position peaked at $183K in Q2 2025. 37 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

Kingswood Wealth Advisors held 52,000 shares of aTyr Pharma worth $31K as of Q2 2026.
Kingswood Wealth Advisors left its aTyr Pharma share count unchanged in Q2 2026.
aTyr Pharma made up ﹤0.01% of Kingswood Wealth Advisors's portfolio in Q2 2026, its #991 holding.
Kingswood Wealth Advisors first reported a position in aTyr Pharma in Q1 2024 and has held it in 7 quarters since.
Kingswood Wealth Advisors's aTyr Pharma position peaked at $183K in Q2 2025.
37 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Kingswood Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.